Boston Scientific to pay $230M for majority stake in devicemaker

Marlborough, Mass.-based Boston Scientific entered into a definitive agreement to shell out $230 million for Synergy’s M.I. Tech, a medical device manufacturer and distributor, for a 64 percent stake by the end of 2022.

Advertisement

M.I. Tech specializes in devices for endoscopic and urologic procedures, according to the June 15 press release. The deal is subject to customary closing conditions.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.